Recent results in the mouse model of CLL indicate that an effective anti-leukemia immune response can be obtained by depleting a specific Treg subset in the CLL microenvironment, thereby creating an opportunity to expand a population of cytotoxic CD8+ T-cells. The gene discussed is CD8A; the disease is leukemia.